Our Capitals
Our Capitals
FY25 was characterised by disciplined execution and operational refinement. With the first phase of BECS now firmly embedded, we concentrated on stabilising processes, reducing manual interventions, and unlocking cost efficiencies. These efforts contributed to enhanced accuracy, quicker turnaround times, and a more resilient financial environment.
As we prepare for the second phase rollout of BECS next year, foundational work continued through the Order-to-Collect initiative. Its success in the second phase will depend on smooth integration with upcoming systems and the adoption of more agile strategies for managing private patient billing.
Amid global volatility and economic challenges, our focus on cash collection, expenditure management, and liquidity control remains essential. Strategic partnerships are being reinforced to ensure affordability and ongoing care. SANBS continues to provide trusted blood products and services prioritising quality, cost control, and long-term sustainability.
The Finance team has been resilient through a period of transition and now functions with enhanced stability and cohesion. Although the pressure has eased, their dedication remains steadfast.
Their ongoing diligence has secured timely, accurate financial reporting and robust compliance with all regulatory standards.
Management, supported by the Audit Committee and the Board, achieved strong results during the year. We also sincerely thank the Executive Committee for their continuous support, and the business area teams whose collaboration has fostered significant operational efficiencies.
We appreciate the engagement of our service providers, medical aid partners, and the National and Provincial Departments of Health. These partnerships remain essential to our mission, and we look forward to strengthening our shared commitment to providing reliable, high-quality healthcare services to all.